·
2 Min Read

AMA statement on making naloxone available over the counter

The AMA strongly supports the FDA decision to make the opioid overdose-reversing drug naloxone available over the counter, a position we have long championed.

Press Releases
·
13 Min Read

Feb. 24, 2023: National Advocacy Update

FDA advisory panels vote 19-0 in favor of OTC naloxone and more in the latest National Advocacy Update.

Advocacy Update
·
2 Min Read

AMA: FDA panels’ naloxone recommendation will save lives

Two advisory committees voted today to recommend to the FDA that naloxone, the overdose-reversing drug, be available over the counter.

Press Releases
·
2 Min Read

Jan. 27, 2023: Advocacy Update spotlight on buprenorphine prescribing

Buprenorphine prescribing now available to all DEA-registered physicians and more in the latest Advocacy Update spotlight.

Advocacy Update
·
4 Min Read

Funds will bolster scores of syringe services programs

Formerly called needle-exchange programs, these efforts cut bloodborne infections and overdose deaths, and serve as a bridge to treatment. Learn more.

Behavioral Health
Delegates stand in line to speak at the 2022 Interim Meeting
·
3 Min Read

Harm-reduction efforts needed to curb overdose epidemic

AMA backs greater use of point-of-care fentanyl test strips and using opioid-litigation settlement funds to boost physician training. Learn more.

Behavioral Health
·
2 Min Read

AMA to urge using opioid litigation funds to train physicians in opioid treatment

The AMA expanded its opioid litigation policy to emphasize using a portion of the settlement funds to expand physician training for treating opioid use disorder.

Press Releases
Narcan kit
·
3 Min Read

FDA naloxone guidance helps harm-reduction groups’ work to save lives

Learn how new clarity from the FDA on burdensome requirements for bulk purchase of naloxone aid underserved communities.

Behavioral Health
·
1 Min Read

New guidance on naloxone to strengthen work of harm reduction groups

The guidance announced today offers regulatory clarity for harm reduction organizations to purchase naloxone so more will be distributed in communities.

Press Releases